Alogliptin
Product manufactured by Perrigo New York Inc
Indications and Purposes
| 1 Indications And Usage Alogliptin Tablets Are A Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 , 14 ) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1.1 ) 1.1 Monotherapy And Combination Therapy Alogliptin Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus [See Clinical Studies (14) ]. Important Limitations Of Use Alogliptin Tablets Are Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Alogliptin Benzoate |
|
ZINC1011 |